- cafead Mar 02, 2022 at 10:32: AM
via Celyad’s voluntary pause didn’t last long.
The biotech put out word after the market closed Monday that the FDA has swiftly followed up the news of 2 patient deaths and an announced pause with a clinical hold, shifting control over the trial halt to federal regulators.
article source
The biotech put out word after the market closed Monday that the FDA has swiftly followed up the news of 2 patient deaths and an announced pause with a clinical hold, shifting control over the trial halt to federal regulators.
article source